-
1دورية أكاديمية
المؤلفون: Liwing, J., Heeg, B.M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., Anttila, P., Remes, K., Abildgaard, N., Waage, A., Nahi, H.
المصدر: Liwing , J , Heeg , B M , Karstorp , S , Postma , M , Silvennoinen , R , Putkonen , M , Anttila , P , Remes , K , Abildgaard , N , Waage , A & Nahi , H 2015 , ' Trial efficacy vs real world effectiveness in first line treatment of multiple myeloma ' , Haematologica , vol. 100 , E1277 , pp. 512-513 .
مصطلحات موضوعية: beta 2 microglobulin, calcium, multiple myeloma, European, hematology, human, patient, population, potential difference, data base, blood, gender, overall survival, Sweden, registration, Norway, Finland, clinical practice, patent, Denmark, hospital, non profit organization, clinical trial (topic)
وصف الملف: application/pdf
-
2دورية أكاديمية
المؤلفون: Joosten, Michel M., Pai, Jennifer K., Bertoia, Monica L., Gansevoort, Ron T., Bakker, Stephan J. L., Cooke, John P., Rimm, Eric B., Mukamal, Kenneth J.
المصدر: Joosten , M M , Pai , J K , Bertoia , M L , Gansevoort , R T , Bakker , S J L , Cooke , J P , Rimm , E B & Mukamal , K J 2014 , ' β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease ' , Journal of the American Heart Association , vol. 3 , no. 4 , e000803 . https://doi.org/10.1161/JAHA.114.000803Test
مصطلحات موضوعية: creatinine, cystatin C, kidney, peripheral artery disease, beta(2)-microglobulin, GLOMERULAR-FILTRATION-RATE, ANKLE BRACHIAL INDEX, LOWER-EXTREMITY, CARDIOVASCULAR EVENTS, RENAL-INSUFFICIENCY, PRACTICE GUIDELINES, MULTIPLE-MYELOMA, KIDNEY-FUNCTION, TASK-FORCE, MORTALITY
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1161/JAHA.114.000803Test
https://hdl.handle.net/11370/c57de7a3-7009-40f8-94ee-ab94a84cb8ecTest
https://research.rug.nl/en/publications/c57de7a3-7009-40f8-94ee-ab94a84cb8ecTest
https://pure.rug.nl/ws/files/15555339/J_Am_Heart_Assoc_2014_Joosten_.pdfTest -
3دورية أكاديمية
المؤلفون: Liwing, J., Heeg, B.M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., Anttila, P., Remes, K., Abildgaard, N., Waage, A., Nahi, H.
المصدر: Liwing , J , Heeg , B M , Karstorp , S , Postma , M , Silvennoinen , R , Putkonen , M , Anttila , P , Remes , K , Abildgaard , N , Waage , A & Nahi , H 2015 , ' Is a deep response the key to successful treatment of multiple myeloma? ' , Haematologica , vol. 100 , pp. 92 .
مصطلحات موضوعية: albumin, creatine, beta 2 microglobulin, calcium, multiple myeloma, European, hematology, human, patient, proportional hazards model, Finland, response time, Denmark, therapy, hospital, independent variable, male, gender, overall survival, hazard ratio, data base, Sweden, Norway, treatment response, chemotherapy
-
4دورية أكاديمية
المؤلفون: Jordanova, ES, Riemersma, SA, Philippo, K, Schuuring, E, Kluin, PM
المصدر: Jordanova , ES , Riemersma , SA , Philippo , K , Schuuring , E & Kluin , PM 2003 , ' beta(2)-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system ' , International Journal of Cancer , vol. 103 , no. 3 , pp. 393-398 . https://doi.org/10.1002/ijc.10824Test
مصطلحات موضوعية: beta(2)-microglobulin, diffuse large B-cell lymphoma, HLA class I, mutation, MHC CLASS-I, MICROSATELLITE INSTABILITY, MISMATCH REPAIR, MONOCLONAL-ANTIBODIES, GENETIC ALTERATIONS, COLORECTAL-CANCER, GASTRIC LYMPHOMA, DOWN-REGULATION, HNPCC PATIENTS, HLA-A
الإتاحة: https://doi.org/10.1002/ijc.10824Test
https://hdl.handle.net/11370/e1db8bd4-e6bd-445d-bedf-6da5190c7c4fTest
https://research.rug.nl/en/publications/e1db8bd4-e6bd-445d-bedf-6da5190c7c4fTest -
5دورية أكاديمية
المؤلفون: Zwaveling, JH, Hoekstra, HJ, Maring, JK, vonGinkel, RJ, Smit, AJ, Girbes, ARJ, Schraffordt Koops, H.
المصدر: Zwaveling , JH , Hoekstra , HJ , Maring , JK , vonGinkel , RJ , Smit , AJ , Girbes , ARJ & Schraffordt Koops , H 1997 , ' Renal function in cancer patients treated with hyperthermic isolated limb perfusion with recombinant tumor necrosis factor-alpha and melphalan ' , Nephron , vol. 76 , no. 2 , pp. 146-152 .
مصطلحات موضوعية: nephrotoxicity, tumor necrosis factor-alpha, isolated limb perfusion, beta(2)-microglobulin, sepsis syndrome, PHASE-I TRIAL, INVOLVEMENT, FLOW, TNF
